About
Dr Prajwol Shrestha is a Medical Oncologist practising at Calvary Mater Newcastle and Lake Macquarie Private Hospitals. He provides care across a range of cancer types, mainly GI, breast, skin and H&N cancers.
His early medical training was undertaken at Liverpool, Gosford and Nepean Hospitals, with completion of Basic Physician Training in 2018. Dr Shrestha completed his specialist training in Medical Oncology at Calvary Mater Newcastle and the Central Coast Cancer Centre. He subsequently undertook a fellowship in early-phase clinical trials at Chris O’Brien Lifehouse in Sydney. Prior to relocating to Newcastle, he also worked in a range of clinical settings across Queensland and South Australia.
Dr Shrestha’s emphasizes on individualised treatment with plan tailored to each patient’s clinical needs and preferences, with the aim of supporting both treatment outcomes and quality of life.
Alongside his clinical work, Dr Shrestha is actively involved in clinical research. He has a particular interest in biomarker-driven clinical trials and has undertaken research into liquid biopsy biomarkers in Centenary Institute, RPA. He is a member of several professional organisations, including the American Society of Clinical Oncology, the European Society of Medical Oncology, and the Medical Oncology Group of Australia. He has authored multiple peer-reviewed publications and has presented his work at national and international conferences.
His early medical training was undertaken at Liverpool, Gosford and Nepean Hospitals, with completion of Basic Physician Training in 2018. Dr Shrestha completed his specialist training in Medical Oncology at Calvary Mater Newcastle and the Central Coast Cancer Centre. He subsequently undertook a fellowship in early-phase clinical trials at Chris O’Brien Lifehouse in Sydney. Prior to relocating to Newcastle, he also worked in a range of clinical settings across Queensland and South Australia.
Dr Shrestha’s emphasizes on individualised treatment with plan tailored to each patient’s clinical needs and preferences, with the aim of supporting both treatment outcomes and quality of life.
Alongside his clinical work, Dr Shrestha is actively involved in clinical research. He has a particular interest in biomarker-driven clinical trials and has undertaken research into liquid biopsy biomarkers in Centenary Institute, RPA. He is a member of several professional organisations, including the American Society of Clinical Oncology, the European Society of Medical Oncology, and the Medical Oncology Group of Australia. He has authored multiple peer-reviewed publications and has presented his work at national and international conferences.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Prajwol Shrestha
Education & training
-
2001–2007 MD · Medicine and Surgery
-
2007–2011 Residency · Oncologia
-
2011–2012 Fellowship · Subspecialty training
Career & appointments
-
2011-09–2012-08 Junior consultant
Licenses & insurance
Medical licenses
AU — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncologia
Malpractice insurance:
AmTrust Europe · 1,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,258 |
| Annual physical exam | 99395 | 668 |
| Vaccination administration | 90471 | 2,340 |
| Minor procedure (skin) | 17110 | 851 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 720.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 17 · i10: 6
-
Outcomes of Oncologia in adults — a multi-centre cohort
DOI: 10.7976/euroclin.2025.0 · PMID: 37197950 · cited by 122
-
European registry analysis of Oncologia outcomes
DOI: 10.1367/euroclin.2024.1 · PMID: 37903200 · cited by 176
-
Outcomes of Oncologia in adults — a multi-centre cohort
DOI: 10.8106/euroclin.2023.2 · PMID: 39871204 · cited by 134
Invited talks
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · Gateshead · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncologia — Gateshead · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2012
- national college of family doctors — Member · since 2012
- European Union of Medical Specialists (UEMS) — Member · since 2012
Articles by this doctor
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
For international patients
- Coordinator
- Patient liaison · prajwol.shrestha@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Location
1 tagPatient reviews
4 verified reviews4.83
★★★★⯨
4 reviews
- Bedside Manner
- 4.9
- Knowledge
- 4.9
- Wait Time
- 4.6
- Staff Friendliness
- 4.9
- Ease Of Appointment
- 4.7
- Value For Money
- 4.8
- Would Recommend Pct
- 96.0
Share your experience — help other patients find the right doctor. Write a review →
Recent reviews
-
★★★★★ ✓ Verified Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verified Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verified Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
